To complement these overexpression models, we also stably knocked out RUNX1T1 in three SCLC cell lines with high endogenous RUNX1T1 mRNA expression levels (H1694, H2171, H82) using CRISPR/Cas9. This evidence concerns the gene RUNX1T1 and small cell lung carcinoma.